Hostname: page-component-5c6d5d7d68-wtssw Total loading time: 0 Render date: 2024-08-07T07:18:15.823Z Has data issue: false hasContentIssue false
  • English
  • Français

Friedreich's Ataxia 1979: An Overview

Published online by Cambridge University Press:  18 September 2015

A. Barbeau
A. Barbeau*
Affiliation:
the Department of Neurobiology, Clinical Research Institute of Montreal
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This overview summarizes the investigations carried out during the second part of Phase Two of the Quebec Cooperative Study of Friedreich's Ataxia. These investigations outline in more details the fundamental role played by an abnormality in the fatty acid composition (deficient linoleic acid, 18:2) of the cholesterol esters of high density lipoproteins (HDL) in the phenotypic expression of the disease. They postulate a defective incorporation of linoleic acid to surface phos-phatidylcholine of chylomicrons and consequent relative and absolute decreases in lipoproteinprotein components because of overpacking with defective cholesteryl esters. Secondarily to these changes, the postulated lack of activation of the lipoamide dehydrogenase (LAD) of the pyruvate dehydrogenase (PDH) complex could result in slow pyruvate oxidation, glucose intolerance, deficient synthesis of acetylcholine, and depletion of glutamic and aspartic acid pools. In parallel, abnormal phosphatidyl-choline molecules could be incorporated to membranes, resulting in specific defects in some functions of these membranes, including transport of calcium and I or taurine and myelinization. The framework of an understanding of Friedreich's ataxia is now available, but much fundamental and clinical work remains to be done to fill in and prove each one of these postulated steps.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 6 , Issue 2 , May 1979 , pp. 311 - 319
Copyright
Copyright © Canadian Neurological Sciences Federation 1979

References

Bar, R. S., Levis, W. R., Rechler, M. M., Harrison, L. C., Siebert, C., Podskalny, J., Roth, J. and Muggeo, M. (1978). Extreme insulin resistance in ataxia telangiectasia. Defect in affinity of insulin receptors. New Engl. J. Med. 298: 1164–1171.Google ScholarPubMed
Barbeau, A. (1976). Friedreich's Ataxia 1976 — An overview. Can. J. Neurol. Sci. 3: 389–397.Google ScholarPubMed
Barbeau, A. (1978). Friedreich's Ataxia 1978 — An overview. Can. J. Neurol. Sci. 5: 161–165.Google ScholarPubMed
Blecher, M. (1979). Cell-surface receptors in health and disease. Clin. Chem. 25: 11–19.Google ScholarPubMed
Butterworth, R. F., Hamel, E., Landreville, F. and Barbeau, A. (1978). Cerebellar ataxia produced by 3-acetyl pyridine in rat. Can. J. Neurol. Sci. 5: 131–134.Google ScholarPubMed
Dyck, P. J. and Lais, A. C. (1973). Evidence for segmental demyelination secondary to axonal degeneration in Friedreich's ataxia.In: Clinical Studies in Myology, Kakulas, B.A. (Ed.). Excerpta Medica, Amsterdam, pp. 253–263.Google Scholar
Filla, A., Butterworth, R. F., Geoffroy, G., Lemieux, B. and Barbeau, A. (1978). Platelet taurine uptake in spinocerebellar degeneration. Can. J. Neurol. Sci. 5: 119–123.Google ScholarPubMed
Gibson, G. E., Jope, R. and Blass, J. P. (1975). Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem. J. 148: 17–23.Google ScholarPubMed
Huang, Y. S., Nestruck, A. C., Barbeau, A., Bouchard, J. P. and Davignon, J. (1978). Plasma lipids and lipoproteins in Friedreich's ataxia and Familial Spastic Ataxia — Evidence for an abnormal composition of high density lipoproteins. Can. J. Neurol. Sci. 5: 149–156.Google ScholarPubMed
Lubozynski, M. F. and Roelofs, R. I. (1975). Friedreich's ataxia. Southern Med. J. 68: 757–763.Google ScholarPubMed
Norum, K. R., Glomset, J. A. and Gjone, E. (1972). Familial lecithin-cholesterol acyl transferase deficiency.In: The Metabolic Basis of Inherited Disease, Third Edit. (Stanbury, J. B., Wyngaarden, J. B. and Fredrickson, D. S., Eds.), McGraw-Hill, New York, pp. 531–544.Google Scholar
Perry, T. L., Hansen, S., Currier, R. D. and Berry, K. (1978). Abnormalities in neurotransmitter amino acids in dominantly inherited cerebellar disorders. Adv. Neurol. 21: 303–314.Google ScholarPubMed
Robinson, N. (1968). Chemical changes in spinal cord in Friedreich's ataxia and motor neurone disease. J. Neurol. Neurosurg. Psychiat. 31: 330–333.Google ScholarPubMed
Tyrer, J. H. (1975). Friedreich's Ataxia. In: Handbook of Neurology, Vol. 22 (Vinken and Bruyn, Eds.), pp. 319–364.Google Scholar
Yao, J. K., Ellefson, R. D. and Dyck, P. J. (1976). Lipid abnormalities in hereditary neuropathy, part I. Serum non-polar lipids. J. Neurol. Sci. 29: 161–175.Google ScholarPubMed